Soft-mist inhalation (SMI) technology allows for delivery of inhalation drugs from a small, portable hand-held inhaler device without the use of propellants
Preclinical data demonstrate sotrovimab, authorised in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron
TIB Molbiol excels in ultra-rapid assay development for emerging infectious diseases, strongly demonstrated during the Covid-19 pandemic
The country’s top heart transplant surgeon Dr. K.R Balakrishnan to be leading the programme for Jaslok
According to a survey conducted by FOGSI last year, 92% of the doctors opined that anaemia due to iron deficiency can be eradicated in five years
The Omicron variant doesn't escape RTPCR and RAT; States advised to ramp up testing for prompt and early identification of any cases
Booster dose is available to all residents aged 18+ and can be applied six months after the second dose of any other vaccine administered in UAE
Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
This collaborative nursing conference generated a positive dialogue on how the healthcare space of nursing has evolved in the past year
Subscribe To Our Newsletter & Stay Updated
